Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]
Cory Tichauer, ND - Immune Dysfunction in Post-Treatment Lyme Disease I (2019 Conference) (LDN, low dose naltrexone)
Cory Tichauer, ND - Immune Dysfunction in Post-Treatment Lyme Disease: Using Naltrexone to Balance Chronic Inflammation I (2019 Conference) (LDN, low dose naltrexone)
Dr Tichauer begins by highlighting that Chronic Lyme Disease has many overlapping symptoms from PTLS but can also involve other organ dysfunction due to active infections still causing tissue damage.
It is also stated that bacterial DNA will continue to be present in low levels in latent infections and can persist for extended periods of time following an active infection. Degraded sections found on urinary PCR testing may only support this reality.
Antigenic debris can also persist following treatment, yet Dr Tichauer proves that Low Dose Naltrexone (LDN) can be effective in preventing reinfection.
This is a summary of Dr Cory Tichauer’s presentation. Please listen to the rest of Dr Tichauer’s presentation by clicking on the video above.